Evolution Advisers’s Amgen AMGN Stock Holding History

Evolution Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73K	Buy	202 +2	+1%	+$685	0.03%	90
2026 Q1	$70K	Hold	200	–	–	0.03%	76
2025 Q4	$65K	Hold	200	–	–	0.03%	84
2025 Q3	$59K	Hold	200	–	–	0.03%	86
2025 Q2	$55K	Hold	200	–	–	0.03%	87
2025 Q1	$62K	Hold	200	–	–	0.03%	81
2024 Q4	$52K	Hold	200	–	–	0.03%	87
2024 Q3	$64K	Hold	200	–	–	0.03%	80
2024 Q2	$62K	Hold	200	–	–	0.04%	79
2024 Q1	$57K	Hold	200	–	–	0.03%	85
2023 Q4	$59K	Buy	+200	New	+$54.5K	0.04%	77

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Evolution Advisers's AMGN Position: Q2 2026 in Review

Evolution Advisers increased its Amgen (AMGN) stake by 1% in Q2 2026, buying an estimated $685 and bringing the position to 202 shares worth $73K. The position accounts for 0.03% of the portfolio, ranked #90.

Evolution Advisers first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Evolution Advisers held 202 shares of Amgen worth $73K as of Q2 2026.
Evolution Advisers bought 2 Amgen shares in Q2 2026, an estimated $685.
Amgen made up 0.03% of Evolution Advisers's portfolio in Q2 2026, its #90 holding.
Evolution Advisers first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.